Latest Breaking News On - Hanmi pharmaceutical - Page 15 : comparemela.com

Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting

Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLisa wilsonAboutspectrum pharmaceuticals incSpectrum pharmaceuticalsDrug administrationSite communications incExchange commissionSpectrum pharmaceuticals nasdaqSpectrum pharmaceuticals incOncologic drugs advisory committeeWall streetTom rigaChief executive officerHanmi pharmaceuticalRegarding forward looking statementsAnnual report

Spectrum Pharma (SPPI) says FDA committee voted 9-4 that current benefits of poziotinib did not outweigh its risks

Spectrum Pharma (SPPI) says FDA committee voted 9-4 that current benefits of poziotinib did not outweigh its risks
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLisa wilsonAboutspectrum pharmaceuticals incSpectrum pharmaceuticalsDrug administrationSite communications incExchange commissionSpectrum pharmaceuticals nasdaqSpectrum pharmaceuticals incOncologic drugs advisory committeeTom rigaChief executive officerHanmi pharmaceuticalRegarding forward looking statementsAnnual reportAll rights

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesSpectrum pharmaceuticals nasdaqExchange commissionOncologic drugs advisory committeeSpectrum pharmaceuticals incAboutspectrum pharmaceuticals incSpectrum pharmaceuticalsDrug administrationTom rigaChief executive officerHanmi pharmaceuticalRegarding forward looking statementsAnnual report

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalFrancois lebelRobert uhlXiuning leExchange commissionSpectrum pharmaceuticals incEuropean society for medical oncology congressSpectrum pharmaceuticalsPatient groupHigh activityNon small cell lung cancerAssistant professorCancer centerEuropean societyMedical oncology congress

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients wi

BOSTON (BUSINESS WIRE) Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled: High Activity of Poziotinib in G778 P780dup HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer (N.

United statesFrance generalFrancois lebelRobert uhlXiuning leExchange commissionSpectrum pharmaceuticals incEuropean society for medical oncology congressSpectrum pharmaceuticalsPatient groupHigh activityNon small cell lung cancerAssistant professorCancer centerEuropean societyMedical oncology congress